Speakers

Giancarlo Agnelli, William Auger, Geoffrey Barnes , Shannon M. Bates, Terry R. Bowers , Scott Cameron, Brett Carroll, Richard Channick, Jean M. Connors, Bruce Davidson, George Davis, Suhail Dohad, James Douketis, Robert Eberhardt, Sabine Eichinger, Abimbola Faloye, John Fanikos, Christina Fanola, Timothy M. Fernandes, Oren Friedman, Jay Giri, Joshua Goldberg, Deepa Gopalan, Charles Grodzin, Emily Gundert, John C. Gurley, Sara Hegab, Brandon Hooks, James Horowitz, Menno Huisman, Wissam Jaber, David Jimenez, Scott Kaatz, Christopher Kabrhel, Brent Keeling, Andrew Klein, Jeffrey Kline, Frederikus A (Erik) Klok, Stavros Konstantinides, Irene Lang, Matthew Langston, Omar M. Lattouf , Lindsay Lief, Robert Lookstein, Robert Maholic, Michael McDaniel, Geno Merli, John Moriarty, Tim Morris, Soophia Naydenov, Oisin O'Corragain, Gregory Piazza, Hooman Poor, Parth Rali, Belinda Rivera-Lebron, Josanna Rodriguez-Lopez, Kenneth Rosenfield, Rachel Rosovsky, Charles B. Ross, Fabio H. Rossi, Eric Secemsky, Susan Smyth, Keith Sterling, Victor Tapson, Aaron Weinberg, Ido Weinberg, Philip Wells, Frances Mae West, Alison Witkin, Zhenguo Zhai

Giancarlo Agnelli

Professore di Medicina Interna, Università di Perugia
Editor-in-Chief European Journal of Internal Medicine
Direttore Medicina Interna, Vascolare e d'Urgenza - Stroke Unit
Ospedale S. Maria della Misericordia, Perugia

Back to top

William Auger, MD

Faculty
Temple University, Philadelphia

Earning his medical degree from the University of Rochester School of Medicine and Dentistry (1982), Dr. Auger subsequently completed his Internal Medicine residency at Strong Memorial Hospital in Rochester, New York in 1985. After a Pulmonary and Critical Care fellowship at the University of California, San Diego, Dr. Auger accepted a faculty appointment at UC San Diego in 1989. It was there that he devoted more than 32 years to the management of patients with chronic thromboembolic pulmonary hypertension (CTEPH), directing the development of one of the leading CTEPH and Pulmonary Thromboendarterectomy Programs in the world. In 2018, Dr. Auger retired from UC San Diego as a Professor of Clinical Medicine. However, his clinical and academic work in the evaluation and treatment of chronic thromboembolic disease and other large vessel pulmonary vascular disorders continues with the acceptance of a faculty appointment at Temple University in Philadelphia in November 2018.
Dr. Auger is a member of the American Thoracic Society, the International CTEPH Association, the Pulmonary Vascular Research Institute, the Pulmonary Hypertension Association, and is a fellow of the American College of Chest Physicians. In 2017, Dr. Auger was appointed the inaugural chair of the CTEPH Council for the International Society for Heart and Lung Transplantation.

Back to top

Geoffrey Barnes , MD, MSc

Assistant Professor, Internal Medicine
Vascular and Cardiovascular Medicine
Frankel Cardiovascular Center, University of Michigan
Ann Arbor, MI

Dr. Barnes is a cardiologist and vascular medicine specialist at the University of Michigan Frankel Cardiovascular Center. His clinical practice and research focus are on anticoagulation therapy and treatment of patient with venous thromboembolism. He co-directs the UM PERT program.

Back to top

Shannon M. Bates, MDCM, MSc, FRCPC

Professor and Director of Hematology and Thromboembolism
McMaster University

Dr. Bates’ clinical and academic interests are in venous thromboembolism, with a focus on thrombosis issues in women. Dr. Bates has published over 100 peer-review manuscripts and given over 130 invited presentations. She was lead author for the chapter examining the use of antithrombotic agents during pregnancy in the 7th, 8th and 9th editions of the American College of Chest Physicians (ACCP) Evidence-Based Clinical-Practice Guidelines for Antithrombotic and Thrombolytic Therapy and for a new chapter examining the diagnosis of deep vein thrombosis for the 9th edition of those guidelines. She subsequently led the development of recently published guidelines on the prevention and treatment of obstetric-related venous thromboembolism (VTE) for the Anticoagulation Forum. She was the Chair of the American Society of Hematology Guideline Panel on VTE in the context of pregnancy and a member of the panel on VTE diagnosis, both of which published their recommendations in November 2018. On January 1, 2014, Dr. Bates was named McMaster University’s Eli Lilly Canada/May Cohen Chair in Women’s Health. She is the Vice Chair of the Royal College of Physicians and Surgeons of Canada’s Area of Focused Competency Subcommittee in Adult Thrombosis Medicine. She has been an Associate Editor for Thrombosis Research since 2014.

Back to top

Terry R. Bowers , MD, FACC, FSVM

Director, Vascular Medicine
Beaumont Hospitals, Royal Oak and Troy
Founder and Director, PERT, Beaumont Health
Assistant Professor of Medicine
OUWB School of Medicine

Dr. Bowers is an interventional cardiologist and endovascular interventionalist who founded and oversees the robust PERT program at Beaumont hospitals. He is a founding member of the National PERT Consortium. He graduated from the University of Michigan Medical School and completed residency at the University of Minnesota. He then completed fellowships in Cardiology and Interventional Cardiology at Beaumont Hospital and Vascular Medicine and Endovascular Intervention at the Cleveland Clinic Foundation.
His research interests involving the RV date back to the pioneering research done at Beaumont in the late 1990’s on the interventional reperfusion benefits for patients with RV infarct. He has published several peer-reviewed articles on the anatomic, clinical manifestations and treatment strategies for RV infarct. He is now actively involved in research and development of thromboaspiration strategies for pulmonary embolism.

Back to top

Scott Cameron, MD, PHD

Section Head of Vascular Medicine
Cleveland Clinic Foundation

Scott Cameron is a cardiologist and vascular medicine physician. He is an expert in managing acute cardiac and thrombotic emergencies. He is board-certified in internal medicine, vascular medicine, cardiovascular disease, he is a registered physician in vascular interpretation, and he has COCATS II level training in comprehensive echocardiography and nuclear cardiology. He is a fellow of the American College of Cardiology and a Fellow of the Society of Vascular Medicine. He serves on the Editorial Board of ATVB and is an Associate Editor for Vascular Medicine, and is a frequent reviewer for basic and translational research studies for the following journals: Circulation, Circulation Research, American Journal of Medicine, and the Annals of Internal Medicine. He has a basic and translational research laboratory funded by the NHLBI in platelet biology and thrombosis, and has published > 60 manuscripts on vascular biology and thrombosis. He served for 4 years at the University of Rochester as an Assistant Professor of Medicine and Surgery in the cardiac ICU, he was the Assistant Director of the Cardiovascular Disease Fellowship, he started a program in vascular medicine, and he was the founding member and co-Director of Rochester’s Pulmonary Embolism Response Team which received a citation from the hospital Quality and Safety Committee for a dramatic decrease in patient mortality over a two-year period. Scott was recently named the Section Head of Vascular Medicine at the Cleveland Clinic Foundation where he is a staff physician in the Section of Vascular Medicine, and runs as basic research laboratory at the Cleveland Clinic Lerner Research Institute focusing on arterial aneurysmal disease

Back to top

Brett Carroll, MD, RPVI

Instructor in Medicine, Harvard Medical School
Director, Section of Vascular Medicine
Division of Cardiovascular Medicine
Beth Israel Deaconess Medical Center

Dr. Carroll is the Director of the Section of Vascular Medicine at Beth Israel Deaconess Medical Center and is an Instructor in Medicine at Harvard Medical School. He completed his internal medicine residency at Massachusetts General Hospital, general cardiology fellowship at Beth Israel Deaconess Medical Center, and vascular medicine fellowship at Brigham and Women’s Hospital. He co-founded and directs the BIDMC multidisciplinary PE response team. He is also the director of Lymphatic Medicine and medical director of the BIDMC Aortic Center. His research interests include venous thromboembolism, aortic disease, and lymphedema.

Back to top

Richard Channick, MD

Director, Acute and Chronic Thromboembolic Disease Program
Professor of Medicine
David Geffen School of Medicine at UCLA
Division of Pulmonary and Critical Care Medicine
Los Angeles, CA

Richard Channick, MD, is Co-Director of the Pulmonary Vascular Disease Program and Director of the Acute and Chronic Thromboembolic Disease at UCLA Medical Center and is the incoming President of the PERT Consortium. Dr. Channick received his medical degree from Temple University Medical School, where he was elected to the Alpha Omega Alpha Medical Honor Society. He did his residency and was Chief Resident at the University of Massachusetts Medical Center. He did a pulmonary and critical care fellowship at the University of California, San Diego Medical Center. Dr. Channick was at UCSD for 20 years helping build the pulmonary vascular program there. From 2009-2018 he was at Massachusetts General Hospital, Harvard Medical School where he built a large Pulmonary Vascular Program and was a co-founder of both MGH PERT and the PERT Consortium. He has been at UCLA since September 2018, directing the UCLA Acute and Chronic Thromboembolic Disease Program. Dr. Channick has published over 200 original articles, chapters and reviews focused on all aspects of pulmonary hypertension and pulmonary embolism. He serves on many national and international leadership committees including the American Thoracic Society Pulmonary Circulation Program Committee and the American College of Chest Physicians Pulmonary Vascular Disease Network steering committee, past Chair of the Scientific Leadership Committee. . Dr. Channick has served on the steering committees for several pivotal clinical trials in pulmonary vascular disease and lectures nationally and internationally.

Back to top

Jean M. Connors, MD

Medical Director, Hemostatic Antithrombotic Stewardship
Medical Director, Anticoagulation Management Services
Hematology Division, Brigham and Women’s Hospital / Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School

Jean M. Connors, MD is a hematology attending at Brigham and Women’s Hospital and Dana Farber Cancer Institute; the Medical Director of the Anticoagulation Management Services, and the Hemostatic Antithrombotic Stewardship Program; and an Associate Professor of Medicine at Harvard Medical School.

She received a medical degree from The Johns Hopkins University in Baltimore, completed her residency in internal medicine at Beth Israel Deaconess Medical Center in Boson, as well as fellowships in transfusion medicine and hematology & oncology from Brigham and Women’s Hospital.

Dr. Connors is an Associate Editor for the Journal of Thrombosis and Haemostasis and is a member of or holds a leadership role in many professional societies. She has participated in numerous clinical trials for patients with venous thrombosis and for the use of reversal agents for the direct oral anticoagulants, and is leading trials in the area of mechanical circulatory support and cancer associated thrombosis.

Back to top

Bruce Davidson, MD MPH

Pulmonary and Critical Care Medicine, Providence Health System, Seattle WA
Formerly Clinical Professor of Medicine, University of Washington

As a clinician and clinical researcher, Bruce L Davidson has helped develop multiple injected and oral anticoagulants for regulatory approval and provided reviews and participation on guideline committees regarding thrombosis. He served as Associate Editor for CHEST for 20 years for thrombosis-related topics. He will discuss the framework for deciding upon early anticoagulant treatment of acute pulmonary embolism. He also helped lead disease control in the 1990s USA respiratory epidemic resurgence of drug-resistant tuberculosis and will briefly present key fundamental pulmonary concepts essential for COVID-19 control.

Back to top

George Davis, PharmD BCPS

Antithrombosis Stewardship Program Coordinator, Medication Safety, Utilization & Value, UK HealthCare Pharmacy Services
Adjunct Professor, UK College of Pharmacy
UK HealthCare Gill Heart and Vascular Institute
University of Kentucky
Lexington KY

George Davis is Antithrombosis Stewardship Program Coordinator at UK HealthCare Pharmacy Services and Adjunct Professor with University of Kentucky College of Pharmacy. He completed pharmacy residency and research fellowship training at the University of Kentucky and has been a clinical pharmacist at UK HealthCare for over 20 years with practice, teaching, research, and scholarly activity focused in clinical pharmacokinetics, anticoagulation, and internal medicine. In his current position, he is lead pharmacist of the UK HealthCare Antithrombosis Stewardship Program which includes involvement in a multidisciplinary inpatient anticoagulation consult service, quality assurance/safety, and antithrombotic formulary management. Most recently, he has served in a leadership role in development of multidisciplinary Pulmonary Embolism Response Team (PERT) at UK HealthCare and actively involved in the National PERT Consortium including serving as a member of the PERT Consortium Board of Directors and serves on the Education and Clinical Protocols committees.

Back to top

Suhail Dohad, MD

Vascular and Cardiac Interventionalist
Vice Clinical Chief of Cardiology
Medical Director Aortic Disease Director of Ischemic Limb Disease Program Interventional Cardiology Cedars Sinai Heart Institute

Dr. Dohad’s area of expertise is interventional cardiology, high risk coronary interventions, valvular heart disease, peripheral vascular disease, carotid artery disease and aortic diseases with options of various endovascular therapies for these diseases.
He completed his residency in Internal Medicine at Hahnemann University Hospital in Philadelphia, PA. He was then selected to remain as chief resident at Hahnemann University Hospital. He followed that with a fellowship in Cardiovascular Fellowship at Hahnemann University Hospital. He then continued his training in Interventional Cardiology at Hahnemann University Hospital and a fellowship in peripheral vascular diseases and endovascular therapies at St. Elizabeth’s Medical Center in Boston, Massachusetts and Hahnemann University Hospital. After two years of private practice in Orlando, Florida, Dr. Dohad joined the Cardiovascular Medical Group in 2001. In 2015 he joined Cedars-Sinai Medical Group.
He has published widely and is currently a principal investigator or co-investigator in 10 ongoing clinical trials including trials sponsored by the National Institute of Health. Some of the trials include carotid artery stenting trials, minimally invasive stent grafting or thoracic and abdominal aortic aneurysms, Aortic valve disease and cell therapies and interventional therapies for peripheral vascular disease

Back to top

James Douketis, MD, FRCP(C), FACP, FCCP

Staff Physician, Vascular Medicine and General Internal Medicine
St. Joseph’s Healthcare Hamilton
Professor of Medicine, McMaster University
Hamilton, ON Canada

Dr. James Douketis is Staff Physician in Vascular Medicine and General Internal Medicine at St. Joseph’s Healthcare Hamilton, and Professor of Medicine at McMaster University.

He received his M.D. and did his residency in internal medicine at the University of Toronto followed by a thrombosis fellowship at McMaster University.

Dr. Douketis’ research interests include: perioperative antithrombotic therapy and guideline development (2008, 2012, and 2018 ACCP Guidelines); prevention, treatment and prognosis of patients with venous thromboembolism.

Dr. Douketis is President of Thrombosis Canada (www.thrombosiscanada.ca), Associate Editor of Journal of Thrombosis and Haemostasis, Deputy Editor of Annals of Internal Medicine Journal Club, and Editor of Canadian Journal of General Internal Medicine, and has over 300 peer-reviewed publications.

Jim lives in Hamilton with his wife, Dr. Margaret Nowaczyk, a clinical geneticist, and two sons, Jack and Luke, and is a cellist with Symphony-on-the Bay

Back to top

Robert Eberhardt, MD

Independent Reviewer/CME Course Director
Director, Vascular Medical Co-Director, Non-Invasive Vascular Laboratory Associate Professor of Medicine, Boston University School of Medicine

Back to top

Sabine Eichinger, MD

Associate Professor of Medicine Medical University Hospital of Vienna, Austria

Dr. Eichinger is associate professor of medicine at the Medical University Hospital of Vienna, Austria. She received her training at the Medical University of Vienna and at the Harvard Medical School in Boston. She has vast expertise in thrombosis and haemostasis and is a specialist in clinical studies. Dr. Eichinger is board member of the European Hematology Association. She is past-chairman of the Scientific and Standardizing Committee of the International Society on Thrombosis and Haemostasis and associate editor of the Journal of Thrombosis and Haemostasis. She received several prestigious academic awards and authored numerous top-ranked scientific articles.

Back to top

Abimbola Faloye, MD, FASE, FASA

Director, Mentor ME Mentoring Program
Division Director Cardiothoracic Anesthesiology, Grady Health System, Atlanta, GA
Assistant Professor, Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA

Dr. Bola Faloye is the Division Director of Adult Cardiothoracic Anesthesiology at Grady Memorial Hospital and an Assistant Professor of Anesthesiology, Emory School of Medicine. Dr. Faloye is a board certified Anesthesiologist with subspecialty training and expertise in adult cardiovascular and thoracic anesthesiology. Clinical interests include intraoperative transesophageal echocardiography and blood conservation strategies in cardiac surgery.

Back to top

John Fanikos, MBA, RPh

Executive Director of Pharmacy Services
Brigham and Women’s Hospital
Adjunct Professor of Clinical Pharmacy
Massachusetts College of Pharmacy and Health Sciences
Boston, Massachusetts


John Fanikos, R.Ph., MBA, is Executive Director of Pharmacy Services at Brigham and Women's Hospital (BWH) in Boston, Massachusetts. He is responsible for the overall Pharmacy Department operations and its financial performance. Mr. Fanikos also serves as Adjunct Professor of Clinical Pharmacy at Massachusetts College of Pharmacy and Health Sciences (MCP). He earned his Bachelor of Science degree in Pharmacy at Massachusetts College of Pharmacy and his Master of Business Administration degree at Northeastern University. He completed an ASHP-accredited residency at BWH.

Mr. Fanikos has served in a number of different roles at BWH, including investigational drug pharmacist, inpatient and outpatient pharmacy supervisor, clinical preceptor, and pharmacy administrator. While fulfilling these roles, he has worked with patients on orthopedic, oncology, cardiology, and general medicine units. He now manages a staff of over 300 pharmacists, pharmacy technicians, and pharmacy interns that provide care across inpatient and ambulatory settings. As part of his research interests, he has worked closely with the BWH Thromboembolism Research Group for over 25 years. He has authored and co-authored over 100 peer reviewed articles and textbook chapters on medication use with a specific emphasis on anticoagulant and antiplatelet therapies. His research focus has been identifying and avoiding the problems and pitfalls of their use.

Mr. Fanikos is a member of the National Comprehensive Cancer Network (NCCN) panel that crafts guidelines for the treatment and prevention of thromboembolic disease. He serves as the treasurer and sits on the Board of Directors for the North American Thrombosis Forum (NATF), a nonprofit organization that provides a platform for those interested in thrombotic disorders to enhance disease education, awareness, advocacy, research, and prevention. He also serves on the Board of Directors for the Hospital Quality Foundation (HQF). Like NATF, HQF is a 503C charitable organization, and it is dedicated to improving the quality of healthcare by supporting the development and delivery of education related to medical practice.

Mr. Fanikos is Past President of the Massachusetts Society of Health-System Pharmacists. Both his father and brother are pharmacists, and graduates of MCP, which makes him aware of many of the issues challenging the medical professionals and college students today

Back to top

Christina Fanola, MD, MSC

Vascular Cardiologist
University of Minnesota Physicians

Dr. Christina Fanola is a vascular cardiologist with the University of Minnesota Physicians and co-founder of the Pulmonary Embolism Response Team at the University of Minnesota. Dr. Fanola graduated from an undergraduate-medical

school program at the George Washington University in Washington, DC and completed internal medicine residency at the Boston University Medical Center. She was a fellow in an NIH-sponsored vascular medicine and research training program affiliated with the

Boston University Medical Center and School of Public Health, where she obtained her Masters Degree in Epidemiology and did research work with antithrombotic drug therapy. She went on to complete her cardiology fellowship training with Boston University and a clinical trials fellowship at Brigham and Women's Hospital and Harvard Medical School. Dr. Fanola has served on multiple committees within the PERT Consortium, Society of Vascular Medicine, American College of Cardiology, American Society of Echocardiography
and American Heart Association. She is the rising co-chair for the Circulation Council of the American Society of Echocardiography and has an interest in the use of ultrasound and echocardiography imaging in advanced venous thromboembolism. Her research has focused on anticoagulant drug therapy, risk stratification in massive pulmonary embolism and advanced catheter-based and mechanical support therapy for patients with right ventricular failure.

Back to top

Timothy M. Fernandes, MD, MPH

Associate Clinical Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Pulmonary Vascular Medicine
University of California, San Diego

Timothy Fernandes, MD, MPH, is an Associate Clinical Professor of Medicine at the University of California, San Diego and a board-certified pulmonologist who focuses on pulmonary vascular disease. He has a special interest in caring for patients who have venous thromboembolism, pulmonary arterial hypertension, and chronic thromboembolic pulmonary hypertension. He co-directs the UCSD Pulmonary Embolism Clinic. Dr. Fernandes is active in clinical research investigating the progression of acute pulmonary embolism to chronic thromboembolic disease (CTEPH), and patient outcomes following pulmonary endarterectomy (PTE) surgery. He has been awarded the CHEST Foundation Clinical Research Grant in Pulmonary Arterial Hypertension, and the Thrombosis and Hemostasis Summit of North America Travel Award.

Back to top

Oren Friedman, MD

Associate Director Cardiac-Surgery Intensive Care Unit
Smidt Heart Institute
Cedars-Sinai Hospital
Los Angeles, California

Oren Friedman, MD is the associate director of the Cardiac-Surgical Intensive care unit within the Division of Cardiothoracic Surgery in the Cedars-Sinai Heart Institute. Dr. Friedman earned his medical degree from Tufts Medical School in Boston Massachusetts. He then completed internship and residency in internal medicine at Tufts New England Medical Center.

Dr. Friedman completed a fellowship in Pulmonary and Critical care medicine at New York Presbyterian(NYP) Hospital. He joined the Pulmonary Critical Care faculty at NYP and was an assistant professor of medicine at Weill Cornell Medical College. He worked primarily in the medical intensive care unit where he introduced and helped develop many new critical care tools including the use of point of care echo and ultrasound, advanced airway management, and various new procedures. Prior to joining Cedars Sinai, Dr. Friedman was instrumental in advancing the practice of therapeutic hypothermia post cardiac arrest and enhancing the practice of resuscitation at the institution. Dr. Friedman was instrumental in co-founding the Cornell PE response team.

At Cedars-Sinai, Dr. Friedman helped initiate and is a key member of Cedars PE response team, and the co-chair of the cardiac arrest committee. Dr. Friedman’s academic interests include acute care airway management, high risk pulmonary embolism, cardiac arrest resuscitation, ECMO-CPR, and veno-venous ECMO. He is involved the international PERT Consortium where he currently serves as the co-chair of the educational committee

Back to top

Jay Giri, MD, MPH

Director, Peripheral Intervention
Associate Director, Penn Cardiovascular Outcomes, Quality & Evaluative Research Center
Hospital of the University of Pennsylvania
Philadelphia, PA

Jay Giri, MD MPH is an Interventional Cardiologist, the Director of Peripheral Intervention at the University of Pennsylvania, the Director of the Cardiovascular Catheterization Laboratory at the Corporal Michael C. Crescenz VA Medical Center in Philadelphia, and the Associate Director of the Penn Cardiovascular Outcomes, Quality & Evaluative Research Center. His clinical interests include complex coronary artery intervention, peripheral artery disease, venous thromboembolism, and transcatheter aortic valve replacement. He performs clinical outcomes and comparative effectiveness research related to emerging endovascular technologies and interventional pharmacotherapies as well as health services and policy research related to cardiovascular medicine. His original research has been published in JAMA, JAMA Internal Medicine, JAMA Cardiology, Journal of the American College of Cardiology, and Circulation among others

Back to top

Joshua Goldberg, MD

Cardiothoracic Surgeon
Surgical Director, Transcatheter Valve and Aortic Surgery
Director, Cardiac Surgery Outcomes Research
Westchester Medical Center/New York Medical College

Back to top

Deepa Gopalan, MRCP, FRCR

Consultant Cardiac Radiologist, Imperial College London & Cambridge
University Hospital, Cambridge, United Kingdom
Academic Associate, Karolinska Institute, Stockholm, Sweden

Deepa Gopalan trained in Radiology at Addenbrooke’s Hospital, Cambridge, and has completed fellowships in Cardiothoracic Radiology at Papworth Hospital, Cambridge, UK and Erasmus MC Hospital, Rotterdam, Netherlands; in Nuclear Medicine at UCH/ Middlesex Hospitals, London, UK; and in Vascular Intervention at the Sheffield Vascular Unit, Sheffield, UK. She is currently the Head of Specialty for Cardiothoracic Radiology at Imperial College London and holds the position of Lead Radiologist for Pulmonary Hypertension Imaging at Hammersmith Hospital, London, Associate Lecturer at Cambridge University, Honorary senior lecturer at Imperial College and Academic Associate at the Karolinska Institute, Stockholm, Sweden. Between 2007 and 2014, she was the Lead Radiologist for Pulmonary Hypertension Imaging at Papworth Hospital, which is also the National Endarterectomy Centre for the UK. She has published widely on her specialist subjects (Pulmonary Hypertension and Noninvasive Cardiac Imaging) and frequently participates as a speaker at national and international cardiovascular conferences.

Back to top

Charles Grodzin, MD

Assistant Professor of Medicine
Medical Director
Department of Respiratory Care
Emory University

Dr. Charles Grodzin is currently an Asst. Prof. of medicine in the department of internal medicine in the section of pulmonary and critical care medicine at Emory University. Dr. Grodzin received his medical training including medical school, internship, residency, chief residency and fellowship at Rush Presbyterian St. Luke’s Medical Center in Chicago. During his training he was the lead author in the textbook “Diagnostic Strategies for Internal Medicine” and a number of book chapters and articles dealing with multiple topics in Pulmonary and Critical Care Medicine. This textbook has sold over 10,000 copies in multiple countries throughout the world and has been used as a teaching tool for medical decision-making. After finishing training he worked in the western suburbs of Chicago in the multispecialty practice in pulmonary and critical care and then moved to the North Dallas area and practiced consultative pulmonary and critical medicine for 15 years. It was his desire to re-enter academic medicine for the sake of teaching residents and fellows that led him to Emory University in July 2014.
Currently, Dr. Grodzin is the medical director of the Department of Respiratory Care, provides medical leadership for the pulmonary embolism response team and is the Emory Midtown lead physician for Sepsis care. Dr. Grodzin has been awarded “Senior Physician” status as a clinical distinction. He is the founder and administrator of pulmonary embolism rounds, the medical director of the pulmonary embolism clinic and attends in the ICU, pulmonary clinic in pulmonary medical consult service at Emory University Hospital Midtown with full teaching responsibilities. Nationally, he is the chairman of the finance committee of the national PERT Consortium as well as a member of the governing and education committees.

Back to top

Emily Gundert, MD FAAEM

Assistant Professor of Emergency Medicine
Assistant Professor of Anesthesia/Pain Management, Division of Critical Care
UT Southwestern

Dr. Gundert is a board certified in both Emergency Medicine and Critical Care and is an Assistant Professor at the University of Texas Southwestern. She splits her clinical time between the Cardiovascular ICU where she is part of the ECMO team and the Parkland ED. Her research interests include ECMO in PE, ECPR, RVD in PE and alternative blood products. She enjoys clinical education and procedural teaching. She spends her off time doing Cross Fit, cooking and learning flying trapeze with her husband Donovan.

Back to top

John C. Gurley, MD

Director, Structural Heart Program
University of Kentucky Healthcare

Dr. Gurley is a visionary leader in the medical field who has devoted his career to saving and improving lives. Dr. Gurley has developed a busy interventional cardiology practice within the University of Kentucky’s Gill Heart & Vascular Institute and has a reputation for successfully overcoming clinical challenges and giving patients years of life when their prognosis was otherwise very dim.

Dr. Gurley earned an MD from the Ohio State University College of Medicine and Public Health in Columbus, Ohio. He completed a residency in internal medicine at NE Ohio University and a fellowship in cardiology at the University of Kentucky.

He is certified by the American Board of Internal Medicine in cardiovascular disease and interventional cardiology.

Dr. Gurley is an elected board member to the American Heart Association and has been an invited speaker for numerous national and international scientific meetings.

Clinical interests include Cardiovascular Interventions, Minimally Invasive Cardiac Procedures, Patent Foramen Ovale/Atrial Septal Defect (PFO/ASD) Closures, and Valvuloplasty.

Back to top

Sara Hegab, MD

Associate Director, Pulmonary Hypertension Program
Medical Director, Pulmonary Embolism Response Team
Division of Pulmonary and Critical Care Medicine, Henry Ford Hospital
Assistant Professor, Wayne State University School of Medicine

Sara Hegab, is a board certified Pulmonary and Critical Care Medicine specialist and is the Associate Director of the Pulmonary Hypertension Program, nationally accredited as a Pulmonary Hypertension Comprehensive Care Center, and the Medical Director of the Pulmonary Embolism Response Team at Henry Ford Hospital in Detroit, Michigan. Additionally, Dr. Hegab is a faculty member of Wayne State University, School of Medicine. Dr. Hegab received her medical degree from Alexandria University in Alexandria, Egypt and completed her residency training in Internal Medicine and fellowship training in Pulmonary and Critical Care Medicine at Henry Ford Hospital. She has published on CTEPH and PH in peer reviewed journals, contributed textbook chapters on CTEPH, is sub-PI on several clinical trials in the area of pulmonary hypertension and is a reviewer for Heart Failure Reviews and Chest. Dr. Hegab is a sought after speaker, both regionally and nationally, and is active in her professional societies, the American College of Chest Physicians, American Thoracic Society and the Pulmonary Hypertension Association.

Back to top

Brandon Hooks, DO, FCCP, FACOI

Pulmonary and Critical Care Medicine, Staff Physician
Physician Champion PERT Ascension Borgess Hospital
Clinical Professor of Medicine
Western Michigan University School of Medicine

Dr. Hooks is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine. Dr. Hooks is the physician champion and founder of the Ascension Borgess Hospital PERT Program and Pulmonary Embolism Follow Up Clinic. He has started three successful PERT programs within community based health systems, one of which was during his Pulmonary and Critical Care Fellowship training. He is a consultant to other community based health systems implementing PERT programs. Within the National PERT Consortium Dr. Hooks has been actively involved in the clinical protocols, finance, and communication committees. He is passionate about pulmonary embolism care and the mission behind PERT Consortium.

Back to top

James Horowitz

Clinical Assistant Professor
Department of Medicine at NYU Grossman School of Medicine

Back to top

Menno Huisman, MD, PhD, FESC

Professor of Medicine.
Internist in Cardiovascular Medicine
Professor of Medicine
Department of Thrombosis and Hemostasis
Leiden University Medical Center
Leiden, the Netherlands

Training:
1975-1983: Medical degree University of Amsterdam, the Netherlands
1983-1988: PhD thesis: ‘Diagnostic management of deep-vein thrombosis’
1988-1994: Training Internal Medicine and Hematology Academic Medical Center Amsterdam, the Netherlands
1994- present: staff member department of Medicine LUMC Leiden, The Netherlands

Research interests
Diagnosis and treatment of venous and arterial thromboembolic disorders

Appointments:
Tutor of Vascular Medicine training LUMC
Chair of DUTCH-AF registry 2017-
Chair of DUTCH-VTE cancer registry 2020-
Chair of Dutch Thrombosis Network
Member of ESC guidelines on PE diagnosis and treatment 2014 and 2019
Member of ACCP guidelines on VTE treatment 2016 en 2020
Chair of Dutch antithrombotic guidelines 2016 and 2019

Back to top

Wissam Jaber, MD

Associate Professor of Medicine, Emory University
Director, Cardiac Catheterization Laboratory at Emory University Hospital

Dr Jaber is director of the cardiac cath lab at Emory University Hospital-Midtown, and director of the complex coronary intervention-CTO program at Emory Heart Center. He finished his residency in Internal Medicine at Duke University, and cardiology fellowship at the Mayo Clinic. After working in private practice, he joined Emory University in 2011, where he helped found the pulmonary embolism team, and lead the complex coronary intervention program

Back to top

David Jimenez, MD, PhD, FERS

Head Respiratory Department
Hospital Ramon y Cajal and Universidad de Alcala IRYCIS
Madrid Spain

Head for Respiratory Department at Ramon y Cajal Hospital, Dr. Jimenez is Associate Professor of Medicine at the University of Alcalá, and Chief of the Venous Thromboembolism Programme at the Ramón y Cajal Hospital in Madrid. At Ramon y Cajal Hospital, he is the Medical director of the PERT program.

Dr Jimenez has participated as Principal Investigator of several randomized clinical trials on thromboembolic prophylaxis and treatment. His research activity focuses on risk stratification and treatment of patients with PE. He was the Chairman of the PROTECT (prognostic value of CT scan for the prognosis of hemodynamically stable patients with PE) and the AINEP (diclofenac for patients with submassive PE) studies, and was a member of the Steering Committee of the PEITHO trial, which assessed the eficacy and safety of thrombolytics in intermediate-risk patients with PE.

He is also a member of several journal editorial boards, and is a peer reviewer for New England Journal of Medicine, The Lancet, JAMA, the Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, or Chest.

Dr. Jimenez is co-chairman of the 10th edition of the Antithrombotic and Thrombolytic Therapy ACCP guidelines, and has been invited speaker at several national and international congresses and in a number of major universities worldwide.

Back to top

Scott Kaatz, DO, MSc, FACP, SFHM

Senior Staff Hospitalist
Medical Director for Professional Development and Research
Division of Hospital Medicine
Henry Ford Hospital

Scott Kaatz is Clinical Professor of Medicine at Wayne State University and a Hospitalist at Henry Ford Hospital in Detroit where he serves as the Medical Director for Professional Development and Research in the Division of Hospital Medicine. He attended medical school at Michigan State University and completed his residency in internal medicine at Henry Ford Hospital. Later in his career, he earned his Master’s degree in Evidence-Based Health Care from Oxford University.
He has a long standing research interest in anticoagulation and thromboembolic disease and was the Medical Director of the Anticoagulation Clinics for the Henry Ford Health System in Detroit, MI for15 years.
Dr. Kaatz is a Fellow of American College of Physicians and a Senior Fellow Society of Hospital Medicine. He is President of the Anticoagulation Forum and past President of the Thrombosis and Hemostasis Societies of North America and the Michigan Chapter of the Society of Hospital Medicine.
He also has serves on the Medical Scientific Advisory Board of the National Blood Clot Alliance and has served on the National Certification Board of Anticoagulation Providers.
He has participated in many research studies with an emphasis on anticoagulation, atrial fibrillation, peri-procedural anticoagulation and venous thromboembolism prevention, diagnosis and treatment; and has published over 250, articles, book chapters and abstracts in this field.

Back to top

Christopher Kabrhel, MD MPH

Director, Center for Vascular Emergencies
Department of Emergency Medicine
Massachusetts General Hospital Associate Professor of Emergency Medicine, Harvard Medical School

Christopher Kabrhel MD MPH is a practicing emergency physician, Director of the Center for Vascular Emergencies at Massachusetts General Hospital (MGH), and Professor of Emergency Medicine at Harvard Medical School. Dr. Kabrhel has more than 15 years of experience performing research into the epidemiology, diagnosis, risk stratification and treatment of acute venous thromboembolism. Dr. Kabrhel's research is funded by the National Institutes of Health, as well as private foundations and industry. He coordinates venous thromboembolism research for the Nurses’ Health Study at Channing Network Medicine at the Health Professionals Follow Up Study at the TH Chan Harvard School of Public Health where he focuses on genetic epidemiology and population risk factors for VTE. To further this work, he co-founded the International Network for Venous Thromboembolism research. In addition to epidemiology, his current work focuses on clinical risk-stratification and novel care delivery methods for patients with acute PE. In 2012, Dr. Kabrhel co-founded the MGH Pulmonary Embolism Response Team (PERT), the first such team in the world as well as the PERT Consortium, a collaboration between PERTs in the United States, South America, Europe and Asia. Dr. Kabrhel is past chair of the PERT Consortium research committee and is on the PERT Consortium Board of Directors

Back to top

Brent Keeling, MD

Associate Professor
Division of Cardiothoracic Surgery
Emory University
Grady Memorial Hospital

Dr. Keeling earned his medical degree at the University of Louisville in 2001, did his general surgery residency at the University of South Florida School of Medicine from 2001-2008, and completed his cardiothoracic surgery fellowship at Emory in 2011. He is currently an associate professor in the Department of Surgery at Emory University, and he serves as the chief of the cardiothoracic surgery program at Grady Memorial Hospital. His clinical interests include valve repair, thoracic aortic pathology, and complex reoperative cardiac surgery. His current research centers on targeted clinical investigations of adult cardiac surgical sub-populations and short- and long-term outcomes for surgery for acute pulmonary embolism.

Back to top

Andrew Klein, M.D., FACC, FSCAI

Interventional Cardiology,
Endovascular/Vascular Medicine
Piedmont Heart Institute
Atlanta, GA

Andrew J.P. Klein, M.D., FACC, FSCAI, is board-certified in endovascular medicine, vascular medicine, interventional cardiology and cardiovascular diseases and internal medicine.
Dr. Klein is a fellow of the American College of Cardiology (ACC) and Society for Cardiovascular Angiography and Intervention (SCAI). An expert in complex coronary and peripheral intervention.
He is an expert in radial cardiac catheterization and has helped Piedmont Hospital become a radial first program.
Dr. Klein has published over 50 peer-reviewed articles and written several book chapters on complex coronary and peripheral intervention and is recognized as a national expert in these arenas.

Back to top

Jeffrey Kline, MD

Vice Chair of Research
Department of Emergency Medicine
Eskenazi Professor, of Emergency Medicine
Indiana University School of Medicine
Editor-In-Chief, Academic Emergency Medicine

Dr. Jeffrey Kline is Vice Chair of Research and Professor of Emergency Medicine at Indiana University School of Medicine. He is the present Editor-in-Chief of Academic Emergency Medicine and is the founding editor and Editor-in-Chief of Academic Emergency Medicine Education and Training. His research centers on thrombosis diagnosis and treatment in the emergency care setting. His interest in diagnosis centers on understanding how emergency clinicians generate hypotheses about the need to test or not test undifferentiated patients for pulmonary embolism. His research into treatment includes large-scale implementation studies of monotherapy anticoagulation to allow home treatment of pulmonary embolism in emergency care, and investigation of protocols to allow safer use of systemically administered fibrinolytic agents.

Back to top

Frederikus A (Erik) Klok, MD PhD

Internist vascular medicine Specialist, Leiden University Medical Center, Leiden, the Netherlands.
Visiting Professor, Center for Thrombosis and Hemostasis, Mainz, Germany.

Frederikus A (Erik) Klok is a board-certified specialist in Internal Medicine, with a specialty in vascular medicine in the Leiden University Medical Center (Leiden, the Netherlands) and holds a position as visiting professor at the Center for thrombosis and Hemostasis in Mainz (Germany). This allows him to combine clinical work with scientific activities. His research interests include the diagnosis, treatment and long-term complications of venous thromboembolism

Back to top

Stavros Konstantinides, MD, PhD, FESC, FRCP(Glasg)

Professor, Clinical Trials, and Medical Director
Center for Thrombosis and Hemostasis (CTH)
Johannes Gutenberg University Mainz

Stavros Konstantinides is Professor for Clinical Trials and Medical Director of the multidisciplinary Center for Thrombosis and Hemostasis (CTH) at the University of Mainz, Germany. The CTH is dedicated to integrated patient care and patient-oriented research, and funded by the federal German government. Dr Konstantinides is also Professor of Cardiology at the Democritus University of Thrace, Greece. He completed his clinical training in Cardiology and gained his doctorate thesis at the University of Freiburg, Germany. He has worked as Consultant Cardiologist, Assistant and Associate Professor of Medicine at the Universities of Freiburg and Goettingen, Germany, and as a Research Associate and Visiting Scientist at the Department of Vascular Biology, the Scripps Research Institute, La Jolla, CA, USA. For the past 30 years, his research has focused on basic mechanisms of thrombosis, and on the risk stratification and risk-adapted antithrombotic management of venous thromboembolism. He has designed and coordinated, and/or has been principal investigator of several high-impact national and international academic and industry-sponsored multicenter trials. His research is funded by national and European peer-reviewed granting agencies. He is leading member of national and European committees, task forces for clinical practice guidelines, and networks focusing on the pulmonary circulation and right ventricular function.

Back to top

Irene Lang, MD

Professor of Vascular Biology
Department of Cardiology
AKH-Vienna, Medical University of Vienna
AUSTRIA

Back to top

Matthew Langston, MD

Assistant Professor of Medicine, AECOM
Director, Medical Intensive Care Unit
Pulmonary/Critical Care, Jacobi Medical Center
Bronx, NY

Dr. Langston completed his medical training at the Loyola University Medical Center and is board certified in Internal Medicine, Pulmonary Medicine and Critical Care. He is the Director of the Medical Intensive Care Unit at Jacobi Medical Center in the Bronx, NY, where he is also an Assistant Professor of Medicine at the Albert Einstein College of Medicine. Clinical interests include pulmonary embolism response team, program development and medical education. A member of the PERT Consortium Educational Sub-committee from its inception, he is involved in a number of initiatives including PERTinent updates and the PERT webinar series in addition to serving on the Finance and Nominations Committees

Back to top

Omar M. Lattouf , MD PHD FACC FACS

Professor of Cardiovascular Surgery
Mount Sinai Morningside Hospital
Emeritus Professor of Surgery / Cardiothoracic
Emory University
President, International Federation of Healthcare Thought Leaders
President, U-Beyond Mentorship
Chair, NAAMA Foundation

Post-Graduate Education:
• Doctorate of Philosophy, Neuroscience (1977) - Emory University
• Doctor of Medicine (1980)- Emory University
• Surgical Leadership Program, Harvard University 2019
Board Certification:
• American Board of Surgery
• American Board of Thoracic Surgery
• Jordan Board of Surgery
National and International Board Appointments:
• President, International Federation of Healthcare Thought Leaders
• Chairman, National Arab American Medical Foundation
• Member, Board of Trustees, Hebron University, Hebron Palestine
• President & Co-founder, U-Beyond Mentorship

Clinical Expertise and Special Accomplishments:
• Certified: American Board of Thoracic Surgery with over 30 years of experience in complex cardiac procedures.
• Active in clinical practice and teaching in Thoracic and Cardiovascular Surgery at Emory University affiliated hospital.
• Clinical areas of interest include:
o On-Pump and Off-Pump Coronary Revascularization,
o Complex Heart Valve Repair and Replacement,
o Lesser Invasive Cardiac Procedures,
o Surgical Correction of Aortic Pathology,
o Lesser Invasive Heart Masses Retrieval using Catheter –based Technology,
o Resynchronization Therapy - Pace Maker implantation,
o Surgical Atrial Fibrillation Therapy,
o Temporary Mechanical Assist Devices
o In 1988 Dr. Lattouf with Emory cardiac colleague co-performed Georgia's first domino heart transplant, and in 1989 participated in implanting the state's first Abiomed biventricular assist system.
o In 2001 performed world's first totally endoscopic left ventricular resynchronization

Back to top

Lindsay Lief, MD

Assistant Attending Physician - NewYork-Presbyterian Hospital
Assistant Professor of Clinical Medicine - Weill Cornell Medical College, Cornell University

Lindsay Lief, MD is an Assistant Professor of Clinical Medicine in the Division of Pulmonary and Critical Care Medicine and the Director of the Medical Intensive Care Unit at New York Presbyterian/ Weill Cornell. She is the medical director of the Pulmonary Embolism Response Team and she founded and directs the Weill Cornell Post-ICU Recovery Clinic.

Dr. Lief attended medical school at Temple University School of Medicine and completed her residency and fellowship at New York Presbyterian/Weill Cornell Medical Center. After completing fellowship training, Dr. Lief served at the Chief Medical Resident at NYP/Weill Cornell.

Dr. Lief devotes her clinical time to caring for critically ill patients and their families, both during their ICU stays and after discharge from the hospital. Her research interests are in identifying and treating unrecognized symptoms in critically ill patients; and in improving outcomes for both ICU patients and their families, as well as the staff providing their care.

Back to top

Robert Lookstein, MD MHCDL FSIR FAHA FSVM

PERT Symposium Co-Chair
Professor of Radiology and Surgery
Vice Chair, Interventional Services
Medical Director, Supply Chain
Mount Sinai Health System
New York, NY

Robert A. Lookstein, MD MHCDL FSIR FAHA FSVM, is Professor of Radiology and Surgery in the Division of Vascular and Interventional Radiology at Icahn School of Medicine at Mount Sinai (ISMMS). In 1995 he graduated from the State University of New York and completed his radiology residency and fellowship in Vascular and Interventional Radiology at ISMMS. In 2002 Dr. Lookstein joined the ISMMS division of Vascular and Interventional Radiology as Faculty.
Dr. Lookstein is the Clinical Director and Chief of the Division of Interventional Radiology serving on committees within the Mount Sinai Health System related to patient safety and quality, novel procedure oversight, cardiovascular disease intervention value analysis and performance improvement.
Lecture topics include: peripheral arterial imaging and intervention, endovascular interventions, aortic stent-grafts and deep vein thrombosis. He is recognized as an innovator in the field of peripheral vascular disease and noninvasive vascular imaging. His clinical practice focuses on diagnosis and treatment of peripheral vascular disease.
Dr. Lookstein is a Member of the Steering Committee of the American Heart Association's Council on Peripheral Vascular Disease and serves as the Chair of the Society of Interventional Radiology (SIR) service line for peripheral arterial disease. Meeting participations include: The International Society of Endovascular Therapy, Advanced Interventional Management, The Society of Interventional Radiology Annual Scientific Meeting, The Radiologic Society of North America, VIVA and Transcatheter Cardiovascular Therapeutics. He is the Program Director of national education courses including Lower Extremity Arterial Revascularization (LEARN) and TransRadial EndovAscular Therapy (TREAT).

Back to top

Robert Maholic, DO, FACC, FSVM

Interventional Cardiologist
UPMC-Hamot, Erie, PA

Robert L. Maholic, DO is board certified in Cardiovascular disease and Interventional cardiology, as well as Vascular and Endovascular medicine. He received his medical degree from Philadelphia College of Osteopathic Medicine in 1999. He completed his advanced training at Allegheny General Hospital in 2006.

Dr. Maholic has been an attending interventional cardiologist at UPMC-Hamot in Erie, PA since 2006. He has a special interest vascular disease, in particular pulmonary embolism and DVT treatment. He sits on multiple hospital and system committees including the vascular process team and the IRB.

He has been a speaker with Abbott vascular and Medrad and consulted with Argon medical. He has participated in several clinical trials including OPTALYSE and FLARE. He currently is a national investigator on KNOCKOUT-PE.

Dr. Maholic has been a member of the PERT Consortium since its inception and currently sits on the board of directors. He helped bring multidisciplinary pulmonary embolism care to UPMC-Hamot in 2012.

Back to top

Michael McDaniel, MD, FACC, FSCAI

Associate Professor of Medicine
Division of Cardiology
Emory University School of Medicine
Director Cardiac Cath Lab, Grady Memorial Hospital

Dr. McDaniel is an interventional cardiologist at Emory University and director of the cardiac cath lab at Grady Memorial Hospital in Atlanta. Dr. McDaniel has an interest in the interventional management of pulmonary embolism, acute coronary syndromes, and cardiogenic shock

Back to top

Geno Merli, MD, MACP, FHM, FSVM

Professor of Medicine and Surgery, Jefferson Medical College
Co-Director Jefferson Vascular Center
Senior Vice President and Associate Chief Medical Officer
Thomas Jefferson University Hospital

Geno J. Merli, is a board-certified specialist in Internal Medicine, is Co-Director of the Jefferson Vascular Center, Thomas Jefferson University and Senior Vice President & Chief Medical Officer at Thomas Jefferson University Hospital. Dr Merli received his medical degree from Jefferson Medical College and completed his residency in rehabilitation medicine and internal medicine at Thomas Jefferson University Hospital. Dr Merli is a nationally recognized expert in the areas of prophylaxis for and management of deep-vein thrombosis and pulmonary embolism (DVT/PE), as well as for the medical consultation of surgical patients. His research interests have focused on prophylaxis for DVT/PE and the management of DVT in medically ill patients, total joint replacement, trauma, and high-risk cancer patients. Dr. Merli serves on the editorial board of Hospitalist News. He is the Editor-in-Chief of Hospital Practice. He is also a reviewer for the New England Journal of Medicine, Archives of Internal Medicine, Annals of Internal Medicine, Chest, Vascular Medicine, Journal of Thrombosis & Haemostasis, and Journal of Thrombosis & Thrombolysis. He is co-editor, with Howard H. Weitz, M.D., of the 3rd edition of Medical Management of the Surgical Patient, and Co-Chairs the Jefferson-Mayo Clinic national course on the perioperative care of the surgical patient with medical problems. In addition, Drs. Merli and Weitz, present an innovative program called “Consult Guys” at the Annual American College of Physicians Meeting and monthly on Annals of Internal Medicine website. Dr Merli is a Master of the American College of Physicians. He is a Fellow of the Society of Hospital Medicine and Society of Vascular Medicine. He is a member of American Venous Forum, the Society of Hospital Medicine, the International Society of Thrombosis and Haemostasis, and Society of Vascular Medicine.

Back to top

John Moriarty, MD FSIR

Program Director
Interventional Radiology
UCLA Medical Center
Los Angeles, CA

Dr John Moriarty is an Interventional Radiologist and Associate Professor of Radiology and Medicine at the David Geffen School of Medicine at UCLA. He is the Director of the UCLA P.E. Response Team, IVC Filter Clinic and the Program for Interventional Innovation. His main clinical and research practice relate to DVT, IVC filters, PE and arterial/aortic interventions. He has given over 100 invited lectures around the world and has over 50 peer reviewed publications. He is the principal investigator on several trials, predominantly related to VTE

Back to top

Tim Morris, MD, FCCP

Professor of Medicine
Clinical Service Chief, Division of Pulmonary and Critical Care Medicine
Medical Director, Respiratory Care Department
Medical Director, Pulmonary Function Laboratory
UC San Diego

Dr. Morris is a clinical expert and a productive investigator in the field of PE. His clinical practice focuses on PE and he has been invited to lecture about PE regularly at the annual meetings of the American Thoracic Society the American College of Chest Physicians and the American College of Physicians. He was honored by the American College of Chest Physicians as the Distinguished Scholar in Thrombosis, the first such award given by the College. He was also awarded a Certificate of Achievement from The American Thoracic Society as their Clinical Expert in Pulmonary Embolism. He has been the sole or contributing author on PE-related chapters in three major pulmonary textbooks. He authored the clinical guidelines for PE diagnosis adopted by the California Thoracic Society. He wrote the section on Pulmonary Vascular Disease for two editions of the American College of Physicians Medical Knowledge and Self Assessment Program (MKSAP). He also completed a project for the Agency for Healthcare Quality and Research (AHRQ) to design and test clinical procedures to reduce the incidence of venous thrombosis and PE.

Dr. Morris’ clinical experience and his expertise in pulmonary vascular biology/physiology give him a unique perspective. He has a longstanding research interest in the pathophysiology of thrombosis and thrombus resolution, and its effect on the outcome of PE. He developed and validated a test to measure the physiological effect of post-PE residual pulmonary artery obstruction on cardiopulmonary function during exercise. His NIH-funded research implicated abnormalities in the structure and function of fibrinogen in the etiology of some patients’ resistance to fibrinolysis, and in the development of CTEPH and chronic thrombotic venous disease. He was the principal investigator of a clinical study to test a novel nuclear medicine technique that he helped develop, which uses radiolabeled anti-D-dimer antibodies to image PE and deep vein thrombi. In a separate project to characterize the acceleration of active thrombosis after acute PE, he developed a clinical assay to measure urinary excretion of fibrinopeptide B.

Back to top

Soophia Naydenov, MD, FCCP

Associate Professor of Medicine
Pulmonary, Critical Care and Sleep Medicine Division SSM Saint Louis University Hospital
Saint Louis, Missouri

Dr. Naydenov is a Pulmonary and Critical Care Medicine specialist and she is currently an Assistant Professor of Internal Medicine at Saint Louis University School of Medicine. She is a graduate of Rawalpindi Medical College in Pakistan. She completed her residency in Internal Medicine at Mercy Medical Center, Saint Louis and pursued her training in Pulmonary and Critical Care Medicine at Saint Louis University. She is one of the founders and the Medical Director of the PERT Program at Saint Louis University. Dr. Naydenov is a pioneer is setting up a dedicated PEClinic in the Greater Saint Louis Area and also led the efforts for a recognition of SSM-Saint Louis University Hospital as a founding member of the National PERT Consortium. Dr. Naydenov is an active member or American Thoracic Society, Society of Critical Care Medicine, European Society of Intensive Care Medicine and American College of Chest Physicians.

Back to top

Oisin O'Corragain, MD

Pulmonary & Critical Care MedicineTemple University Hospital
Philadelphia, PA

Back to top

Gregory Piazza, MD, MS

Staff Physician, Cardiovascular Division
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School

Dr. Piazza is Assistant Professor of Medicine, Harvard Medical School and faculty in the Cardiovascular Division at Brigham and Women's Hospital. Dr. Piazza received his medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts and completed residency in internal medicine, Chief Medical Residency, general cardiology fellowship, and an advanced cardiovascular imaging fellowship at the Beth Israel Deaconess Medical Center in Boston. He also completed an National Heart Lung and Blood Institute-sponsored advanced fellowship in vascular medicine at Brigham and Women’s Hospital. Dr. Piazza’s research interests include the epidemiology, pathophysiology, diagnosis, treatment, and prevention of venous thromboembolism, thrombophilia-associated infertility, computerized decision support to improve cardiovascular outcomes, as well as stroke prevention in atrial fibrillation

Back to top

Hooman Poor, MD

Assistant Professor of Medicine
Director of Pulmonary Vascular Disease, Mount Sinai-National Jewish Health Respiratory Institute
Division of Pulmonary, Critical Care and Sleep Medicine
Zena and Michael A. Wiener Cardiovascular Institute
Icahn School of Medicine at Mount Sinai

Dr. Poor earned his BA in physical chemistry and mathematics from Dartmouth College. He obtained his medical degree at Columbia University and completed his internal medicine and pulmonary and critical care training also at Columbia University. He as been at Mount Sinai since 2013 with appointments in both the Division of Pulmonary and the Division of Cardiology as an Assistant Professor of Medicine. He is the Director of Pulmonary Vascular Disease of the Mount Sinai — National Jewish Health Respiratory Institute, running a large pulmonary hypertension practice. He co-founded and leads the multidisciplinary PERT at Mount Sinai. His research interests include the pulmonary vascular manifestations of COVID-19.

Back to top

Parth Rali, MD

Director, Temple Pulmonary Embolism Response Team
Assistant Professor, Thoracic Medicine and Surgery
Temple University Hospital, Philadelphia

Assistant Professor at Division of Thoracic Medicine and Surgery and founder of Temple Pulmonary Embolism Response Team, Dr Parth Rali is pulmonologist and full time intensivist (Medical and Cardiothoracic surgical ICU) at Temple university hospital, Philadelphia. Dr Rali has great interest in integrating critical care ultrasound as a part of PERT process. Dr Rali is an active member of National PERT consortium and represent in educational, research and protocol committees

Back to top

Belinda Rivera-Lebron, MD, MS, FCCP

Director, Acute and Chronic Thromboembolism Program
Associate Professor of Medicine
University of Pittsburgh
Pittsburgh, PA

Belinda Rivera-Lebron completed her undergraduate and medical school degree in Puerto Rico. Then moved to Boston to pursue an internal medicine internship and residency at the Boston University Medical Center. Subsequently, completed pulmonary and critical care fellowship at the Hospital of the University of Pennsylvania, where she also completed a Master of Science in clinical epidemiology. She is board certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine. In 2013, she joined the Division of Pulmonary, Allergy and Critical Care Medicine of the University of Pittsburgh as an Assistant Professor of Medicine. She specializes in pulmonary hypertension and acute and chronic pulmonary embolism. She is the director of the UPMC Acute Pulmonary Embolus (PE) Team and the Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program. Dr. Rivera has published original research manuscripts, abstracts, reviews, electronic publications, book chapters. She is a member of several professional medical associations, including the American Thoracic Society, the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. She has delivered talks of numerous sessions at many national and international conferences.

Back to top

Josanna Rodriguez-Lopez, MD

Director, Pulmonary Hypertension and Thromboembolic Disease Program
Director, HHT Center, Massachusetts General Hospital, Boston, MA

Dr. Rodriguez-Lopez earned her BA in Biology and French from Boston College and her MD from NYU School of Medicine. She completed her internship and residency in Internal Medicine and her fellowship in Pulmonary and Critical Care at Columbia University Medical Center. She began her career with the Albert Einstein College of Medicine before joining the staff at Massachusetts General Hospital and Harvard School of Medicine in 2013. In 2018 she became the director of the pulmonary hypertension and thromboembolic disease program and she is also the director of the HHT Center of Excellence. In addition, she helped form the multi-disciplinary initiative Pulmonary Embolism Response Team (PERT), which was spearheaded at MGH to improve the coordination and care of patients with acute pulmonary embolism. She also helped establish the PERT follow-up clinic for the long-term management of these patients. Her research interests include chronic thromboembolic disease, post PE syndrome, and HHT.

Back to top

Kenneth Rosenfield, MD, MSC

Section Head Vascular Medicine and Intervention
Massachusetts General Hospital
Boston Massachusetts

Section Head for Vascular Medicine and Intervention in the Division of Cardiology at
Massachusetts General Hospital, Dr. Rosenfield is an interventional cardiologist and
vascular specialist performing complex cardiac and vascular interventions. He earned a
master’s degree in Health Care Delivery Science from Dartmouth College. A clinical
trialist and national principle investigator for several landmark studies, including Levant
2, Superb, ACT 1, and NIH BEST-CLI, he also sat on the Board of Governors of American
College of Cardiology, is past-President of the MA ACC Chapter, and is current President
of the Society for Cardiovascular Angiography and Interventions (SCAI). Dr. Rosenfield is
a founding member of VIVA, a 501c3 organization, and sits on the board of directors. At
Massachusetts General Hospital, he is the Medical director of the PERT Program, which
he founded with his colleagues; he also helped to found the National PERT Consortium,
a 501c3 organization dedicated

Back to top

Rachel Rosovsky, MD, MPH

Director of Thrombosis Research, Department of Hematology
Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Rachel Rosovsky, MD, MPH is an Assistant Physician in the Department of Hematology/Oncology at Massachusetts General Hospital (MGH) and an Assistant Professor in Medicine at Harvard Medical School (HMS). She serves as the Director of Thrombosis Research for the Department of Hematology. She earned her undergraduate degree from the University of Pennsylvania, her medical degree from Harvard Medical School and her Master’s in Public Health from Harvard School of Public Health. She completed her residency at Brigham and Women’s Hospital and her fellowship at the Dana Farber Cancer Institute/MGH combined program.

Dr. Rosovsky is on the Board of Directors of the National Pulmonary Embolism Response Team (PERT) Consortium and as part of this enterprise, she also serves as the Chair of the Education Committee. She is on the Executive Committee of MGH PERT and is the creator and director of MGH PERT multidisciplinary follow up clinic. She is on the Medical and Scientific Advisory Board for the National Blood Clot Alliance (NBCA). She is also on the Executive Committee for the Venous thromboEmbolism Network US (VENUS). She has collaborated locally, nationally and internationally with prominent researchers on the risks, diagnosis and treatment of VTE, and she has published widely in this area. She is the recipient of the MIT IDEAS2 Global Challenge award for developing an affordable system to monitor anticoagulation in patients living in low income countries. Through lecturing, research, and written works, she has sought to improve the care of patients with VTE and advance the understanding and treatment of this medical condition.

Back to top

Charles B. Ross, MD, FACS, DFSVS

Chief, Vascular and Endovascular Services
Co-director. Level I Cardiovascular Emergency Program
Piedmont Heart Institute
Piedmont Atlanta Hospital
Atlanta, Georgia

Dr. Charles Ross has practiced vascular/endovascular surgery since 1991. Dr. Ross founded the pulmonary embolism program with his colleagues at Piedmont Atlanta Hospital in late 2012 which then transitioned to the PAH PERT in 2014. He has participated with colleagues from Emory University, Grady Health System and Wellstar in regional efforts and programs to expand education and awareness of modern care for pulmonary embolism through metro Atlanta and Georgia. Dr. Ross served on the Board of Directors of the PERT Consortium, 2016-2019.

Prior to his recruitment to his present position in Atlanta, Dr. Ross was chief of the division vascular surgery and endovascular therapeutics at the University of Louisville. He is a Distinguished Fellow, Society of Vascular Surgery and member of multiple professional societies including the American Venous Forum, Southern Association for Vascular Surgery, and the PERT Consortium. He has authored, co-authored numerous publications, and he has participated in numerous clinical trials for endovascular devices and procedures including work as an Optalyst trialist. Throughout his career, major endovascular interventions for venous thromboembolic disease including pulmonary embolism as well as caval and iliofemoral reconstruction for both acute and chronic occlusions have been among his major professional interests

Back to top

Fabio H. Rossi, MD

Vascular and Endovascular Surgery
Dante Pazzanese
Sao Paulo - Brazil

Back to top

Eric Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSCVM

Director | Vascular Intervention | Beth Israel Deaconess Medical Center
Director | Vascular Research | Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology | Beth Israel Deaconess Medical Center
Assistant Professor of Medicine | Harvard Medical School

Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSCVM is the Director of Vascular Intervention and an interventional cardiologist at Beth Israel Deaconess Medical Center (BIDMC). He is also the Director of Vascular Research at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology and an Assistant Professor of Medicine at Harvard Medical School. He received his medical degree from Northwestern University and a Master’s of Science in Epidemiology from the Harvard School of Public Health. Dr. Secemsky completed his internal medicine training at the University of California, San Francisco, and Cardiovascular Medicine, Interventional Cardiology, and Vascular Diagnostics and Intervention training all at Massachusetts General Hospital/Harvard Medical School. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab, the cardiac intensive care unit, and the inpatient and outpatient vascular medicine services. Dr. Secemsky is the primary vascular interventionalist within the BIDMC catheterization lab, where he does complex venous and arterial procedures, with a focus on peripheral arterial disease.
Dr. Secemsky also leads the vascular medicine research program at the Smith Center for Outcomes Research in Cardiology. His research involves utilizing real-world data to perform comparative effectiveness and outcomes research, with a focus on the treatment of peripheral vascular disorders. Dr. Secemsky is also involved in clinical trial design and implementation, and has served as an investigator on more than a dozen trials. Dr. Secemsky’s laboratory is funded by numerous philanthropy and extramural grants, including from the National Institute of Health. Dr. Secemsky has authored more than 60 original investigations and has mentored numerous medical students, residents, fellows and junior faculty. He is an Assistant Editor at Circulation: Cardiovascular Interventions and an Associate Editor of Vascular Medicine. He has been an invited lecturer nationally and internationally to speak about his research and he has been the program lead for the American College of Cardiology Scientific Sessions’ Endovascular Program and SCAI Scientific Sessions’s Peripheral Track.

Back to top

Susan Smyth, MD PhD, FACC, FAHA

Jeff Gill Professor and Chief | Cardiology
Director | Gill Heart and Vascular Institute
University of Kentucky

Dr. Smyth is a physician scientist who combines clinical practice in cardiology with NIH- , VA-, and industry-funded research focused on the interplay between inflammation and thrombosis in vascular biology. She has authored nearly 200 publications and contributed to over a dozen textbooks. She leads a multidisciplinary anticoagulant and antithrombosis team for that provides consultative clinical services and oversees anticoagulation stewardship, including the establishment of a PERT team, for UKHealthcare

Back to top

Keith Sterling, MD, FSIR

Chair, Medical Affairs Council
Inova Health System
Chief, Department of Cardiovascular & Interventional Radiology
Inova Alexandria Hospital

Keith M. Sterling, MD,FSIR is an interventional radiologist who has been in practice in Northern Virginia since 1995. He is Chief of Cardiovascular & Interventional Radiology of the Association of Alexandria Radiologists and Medical Director of the Advanced Interventional Vein & Vascular Center. He is currently the Chairman of the Medical Affairs Council for the Inova Health System and the Chair of both the Hospital Quality and Safety Committee and Multispecialty Peer Review Committee at Inova Alexandria Hospital.
He is a Fellow of the Society of Interventional Radiology. He maintains an appointment as Associate Professor of Radiology at George Washington University School of Medicine and has trained residents and fellows over his entire professional career. Dr. Sterling is a frequently invited lecturer and is a nationally-recognized leader in the field of IR. He has been principal investigator on numerous research trials involving thrombolysis, embolization and medical devices. He serves on multiple task forces and committees for the Society of Interventional Radiology and the Inova Health System. He has been consistently recognized by his peers as one of the “Top Doctors” in Washingtonian and Northern Virginia magazines.
Dr. Sterling graduated with honors in 1985 from Northwestern University with a B.S. in Electrical Engineering & Computer Science. He earned his medical degree from New York Medical College in 1989. He served his medical internship at Columbia University College of Physicians & Surgeons in New York. He was a resident in Diagnostic Radiology at Mount Sinai Medical Center in New York and fellowship in Interventional Radiology at the Mallinckrodt Institute of Radiology/Washington University School of Medicine.
His areas of special expertise are venous thromboembolic disease, peripheral arterial disease, vascular malformations, acute stroke therapy and women’s intervention.

Back to top

Victor Tapson, MD

PERT Symposium Co-Chair
Director, Venous Thromboembolism and Pulmonary Vascular
Disease Research Program
Associate Director, Pulmonary
and Critical Care Division
Cedars-Sinai Medical Center
Los Angeles, California

Dr. Tapson has been interested in pulmonary vascular disease since completing his pulmonary / critical care fellowship. Shortly thereafter, he started the Duke Pulmonary Vascular Disease Center and conducted research in PH and pulmonary embolism (PE) including lab-based studies of catheter-directed thrombosis which were ultimately transitioned to the clinical arena.

In the field of venous thromboembolism (VTE), Dr. Tapson has served on the ACCP Consensus Statement for VTE a number of times, beginning in 1995. He served as Chairman for the ATS Consensus Statement and Clinical Practice Guidelines for the Diagnostic Approach to Acute VTE. He has served as world-wide principal investigator or co-PI for venous thromboembolism registries including DVT-FREE, IMPROVE, NABOR, and ENDORSE. He conceived the recently completed OPTALYSE PE trial, and was PI for the BiO2 Angel catheter IVCF study and co-PI for the world-wide TAFIa clinical trial in acute PE, as well as for the FLARE clot-extraction study. In 2014, he left Duke for an outstanding opportunity at Cedars-Sinai Medical Center where he continues this work. He has cared for thousands of patients with acute PE over the past 25 years. He currently serves as President of the U.S. Pulmonary Embolism Response Team Consortium, a growing 501(c)3 organization dedicated to improving the care of acute PE patients.

Back to top

Aaron Weinberg, MD MPhil

Pulmonary, Critical Care, & Internal Medicine
Director of Program Development and Clinical Research
Carbon Health
San Francisco, California

Dr. Weinberg is triple boarded in Pulmonary, Critical Care, and Internal Medicine. Prior to embarking on his medical career, he earned an undergraduate degree in history from the University of California, Los Angeles and a master’s degree in International Relations at the University of Cambridge in England where he authored his thesis on pandemics as an international security threat. He previously served as the associate director of VTE Disease & Research, co-director of the Cedars Sinai PERT Program, and as an assistant professor of medicine on the academic faculty at Cedars Sinai Medical Center in Los Angeles, California. His research interest is venous thromboembolic disease. He is currently the director of program development and clinical research at Carbon Health with the goal of using technology and evidence-based care platforms to facilitate the democratization and access of specialized healthcare across this country. He has been an active member of the National PERT Consortium since its inception and served as the Co-Communications Chair before assuming his current role as a member of the Board of Directors for the National PERT Consortium.

Back to top

Ido Weinberg, MD MSc FSVM

Assistant Professor of Medicine
Harvard Medical School
Medical Director, VASCORE
Co-Medical Director, Anticoagulation Management Services
Massachusetts General Hospital
Boston, MA

Dr. Weinberg is a Vascular Medicine specialist at Massachusetts General Hospital and Assistant Professor of Medicine at Harvard Medical School. He is Medical Director of VASCORE, the Vascular Ultrasound Core Laboratory. He is Co-Medical Director of the MGH Anticoagulation Management Services. He is founder and editor in-chief of Angiologist.com and online portal for vascular disease. Dr. Weinberg is fellowship director for the MGH Vascular Medicine fellowship and co-director for the Vascular Medicine and Intervention fellowship. His research interests are venous thromboembolism, anticoagulation and vascular imaging.

Back to top

Philip Wells, MD, FRCP(C), MSc

Full Professor,
Chair and Chief, Department of Medicine
The University of Ottawa, Faculty of Medicine and The Ottawa Hospital
Senior Scientist, Ottawa Hospital Research Institute

Dr. Wells received his medical school education and specialty training in Internal Medicine at the University of Ottawa. He then studied Hematology and completed a Masters in Clinical Epidemiology at McMaster University, concentrating on the special problems of venous thrombosis (blood clots in the veins). He pioneered the concept of clinical prediction rules to assist in the diagnosis of patients with suspected deep vein thrombosis and/or pulmonary embolism. For each of these diseases he embodied these prediction rules in valuable algorithms now known as the “Wells Model for DVT” and the “Wells Model for PE”. They are currently used world-wide in the diagnostic process for these illnesses and are incorporated into many National and Organizational guidelines.
He established the Thrombosis Treatment and Assessment Unit at The Ottawa Hospital, now the largest thrombosis clinical practice in the world. In March 2009, after 10 years as Division Chief in Hematology, he assumed the position of Chief/Chair of the Department of Medicine at The Ottawa Hospital and the University of Ottawa. The Department consists of 17 Divisions, almost 500 physicians and over 200 post graduate trainees.
Dr. Wells has over 30 million dollars granted in career research funding and has over 340 publications in a wide array of prestigious journals such as the New England Journal of Medicine, JAMA, Circulation, Blood, Nature Genetics and Lancet.

Back to top

Frances Mae West, MD, MS, FACP

Assistant Professor of Medicine
Associate Program Director – Pulmonary & Critical Care Fellowship
Co-Program Director – Internal Medicine Point-of-Care Ultrasound Fellowship
The Jane and Leonard Korman Respiratory Institute
Jefferson Health & National Jewish Health

Dr. Frances Mae West is the Associate Program Director for the Pulmonary and Critical Care Medicine Fellowship. She is the founding Program Co-Director of the Internal Medicine Point-of-Care Ultrasound Fellowship, as well as the Critical Care advisor to the Emergency Medicine Ultrasound Fellowship.

She obtained her medical degree from Jefferson Medical College, followed by Internal Medicine internship, residency and Pulmonary & Critical Care Medicine fellowship at the New York-Presbyterian Hospital – Weill Cornell Medical Center. She is triple board certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine. She is a Testamur of the National Board of Echocardiography’s Special Competence in Critical Care Echocardiography, and is currently on track for board certification.

She is a founding member of Jefferson’s Pulmonary Embolism Response Team (JeffPERT) and a committee member of the National PERT Consortium. Dr. West serves as the Critical Care Course Director for the international Resuscitative Transesophageal Echocardiography (TEE) Workshop. She is a fellow of the American College of Physicians, and holds active memberships in the American Thoracic Society and the American College of Chest Physicians.

Back to top

Alison Witkin, MD

Associate Director, MGH Pulmonary Hypertension and Thromboendarterectomy Program
Division of Pulmonary and Critical Care
Massachusetts General Hospital

Alison S. Witkin the associate director of the Massachusetts General Hospital Pulmonary Hypertension and Thromboendarterectomy Program. Dr. Witkin earned her medical degree from Jefferson Medical College in Philadelphia. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and completed fellowship training in pulmonary and critical care medicine at the Harvard Combined Fellowship
(Massachusetts General Hospital and Beth Israel Deaconess Medical Center). Dr. Witkin’s clinical interests include pulmonary hypertension and acute and chronic pulmonary embolism. She is particularly interested in the follow up care of patients with pulmonary embolism. She is an active member of the Massachusetts General Hospital Pulmonary Embolism Response Team (PERT) and serves as co-chair of the communications committee for the national PERT Consortium. Dr. Witkin is Board Certified in Pulmonary Medicine, Critical Care Medicine, and Internal Medicine


Back to top

Zhenguo Zhai, MD, PhD

Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China.
National Clinical Research Center of Respiratory Diseases;
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences

Back to top